Market Overview:
The global point-of-care coagulation testing market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of thrombotic disorders, rising demand for home care settings, and technological advancements in point-of-care coagulation testing devices. Based on type, the global point-of-care coagulation testing market is segmented into consumables and instruments. The consumables segment is further subsegmented into test strips, lancets, needles, and others (such as pipettes and tips). The instruments segment is further subsegmented into analyzers and monitors. Based on application, the global point-of-care coagulation testing market is divided into hospitals & private clinics and home care settings. Geographically, the global point-of-care coagulation testing market has been analyzed across five regions: North America (the U.S., Canada), Latin America (Mexico & Brazil), Europe (Germany France Italy Spain), Asia Pacific (China Japan India Australia) Middle East & Africa (South Africa Saudi Arabia UAE).
Product Definition:
Point-of-Care Coagulation Testing is a type of blood test that is used to check the clotting ability of the blood. This type of test is important because it can help to diagnose and treat problems with the clotting ability of the blood.
Consumables:
Consumables, it's usage.
Point of care (POC) coagulation testing is a process where tests are carried out onsite at the point of patient care. This assists healthcare professionals to avoid long waiting times associated with results as well as aids in reducing costs by avoiding unnecessary laboratory visits.
Instruments:
Instruments and it's usage in Point-of-Care Coagulation Testing market is used for measuring the coagulation factors (Fibrinogen, Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT)), platelet count, International Normalized Ratio (INR), international prothrombin time, and activated partial thromboplastin time.
Application Insights:
The market is segmented by application into hospitals and private clinics, home care, and others. The hospital and private clinic segment dominated the global point-of-care coagulation testing market in 2017 due to an increase in the prevalence of critical care units at hospitals across the globe. This has led to a rise in demand for point-of-care coagulation tests that are used on a regular basis during emergency situations or surgical procedures.
The home care segment is expected to witness lucrative growth over the forecast period owing to an increase in chronic diseases such as cardiovascular diseases, cancer, diabetes mellitus type 2, respiratory problems among other illnesses that require regular medical checkups at home. Furthermore, rising awareness about these illnesses coupled with increasing disposable income levels among individuals aged 30 years and above will further boost product demand globally over the forecast period.
Regional Analysis:
North America dominated the global point-of-care coagulation testing market in 2017. This can be attributed to the presence of a large number of healthcare providers, advanced diagnostic technologies, and increasing demand for cost-effective treatment options among patients. The U.S., which is at the forefront, has an aging population that requires regular monitoring and management of blood clotting disorders such as deep vein thrombosis (DVT) and Pulmonary Embolism (PE). Moreover, growing awareness about these conditions among people is also expected to drive growth during the forecast period.
In Asia Pacific region, Japan held a significant share in 2017 owing to rapid economic development coupled with government initiatives for improving healthcare infrastructure in emerging countries such as China & India.
Growth Factors:
- Increasing incidence of thrombotic disorders: The global point-of-care coagulation testing market is expected to grow at a CAGR of 7.5% during the forecast period owing to the increasing incidence of thrombotic disorders such as deep vein thrombosis (DVT), pulmonary embolism, and myocardial infarction.
- Growing demand for rapid and accurate diagnosis: The growing demand for rapid and accurate diagnosis is another key factor driving the growth of the point-of-care coagulation testing market. This can be attributed to the increasing number of patients with hematological diseases who require timely treatment decisions.
- Technological advancements in POC coagulation testing devices: Technological advancements in POC coagulation testing devices are also propelling market growth, as these devices offer enhanced accuracy, speed, and convenience compared to traditional laboratory methods. For instance, recent advances in lateral flow technology have led to development of portable blood analyzers that can provide results within minutes without requiring any specialized training or expertise from laboratory technicians or physicians.
Scope Of The Report
Report Attributes
Report Details
Report Title
Point-of-Care Coagulation Testing Market Research Report
By Type
Consumables, Instruments
By Application
Hospitals And Private Clinics, Home Care
By Companies
F.Hoffmann-La Roche, Abbott, Siemens Healthcare, Accriva Diagnostics, CoaquSense, Diagon, Helena Point of Care, HemoSonics, iLine Microsystems, Medtronic, Micropoint Bioscience, Sysmex
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
144
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Point-of-Care Coagulation Testing Market Report Segments:
The global Point-of-Care Coagulation Testing market is segmented on the basis of:
Types
Consumables, Instruments
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals And Private Clinics, Home Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- F.Hoffmann-La Roche
- Abbott
- Siemens Healthcare
- Accriva Diagnostics
- CoaquSense
- Diagon
- Helena Point of Care
- HemoSonics
- iLine Microsystems
- Medtronic
- Micropoint Bioscience
- Sysmex
Highlights of The Point-of-Care Coagulation Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Consumables
- Instruments
- By Application:
- Hospitals And Private Clinics
- Home Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Point-of-Care Coagulation Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Point-of-care coagulation testing is a diagnostic procedure that uses a blood sample to measure the level of clotting factors in the blood. This test can be used to diagnose conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke.
Some of the major players in the point-of-care coagulation testing market are F.Hoffmann-La Roche, Abbott, Siemens Healthcare, Accriva Diagnostics, CoaquSense, Diagon, Helena Point of Care, HemoSonics, iLine Microsystems, Medtronic, Micropoint Bioscience, Sysmex.
The point-of-care coagulation testing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Point-of-Care Coagulation Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Point-of-Care Coagulation Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Point-of-Care Coagulation Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Point-of-Care Coagulation Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Point-of-Care Coagulation Testing Market Size & Forecast, 2018-2028
4.5.1 Point-of-Care Coagulation Testing Market Size and Y-o-Y Growth
4.5.2 Point-of-Care Coagulation Testing Market Absolute $ Opportunity
Chapter 5 Global Point-of-Care Coagulation Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Point-of-Care Coagulation Testing Market Size Forecast by Type
5.2.1 Consumables
5.2.2 Instruments
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Point-of-Care Coagulation Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Point-of-Care Coagulation Testing Market Size Forecast by Applications
6.2.1 Hospitals And Private Clinics
6.2.2 Home Care
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Point-of-Care Coagulation Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Point-of-Care Coagulation Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Point-of-Care Coagulation Testing Analysis and Forecast
9.1 Introduction
9.2 North America Point-of-Care Coagulation Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Point-of-Care Coagulation Testing Market Size Forecast by Type
9.6.1 Consumables
9.6.2 Instruments
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Point-of-Care Coagulation Testing Market Size Forecast by Applications
9.10.1 Hospitals And Private Clinics
9.10.2 Home Care
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Point-of-Care Coagulation Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Point-of-Care Coagulation Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Point-of-Care Coagulation Testing Market Size Forecast by Type
10.6.1 Consumables
10.6.2 Instruments
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Point-of-Care Coagulation Testing Market Size Forecast by Applications
10.10.1 Hospitals And Private Clinics
10.10.2 Home Care
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Point-of-Care Coagulation Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Point-of-Care Coagulation Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Point-of-Care Coagulation Testing Market Size Forecast by Type
11.6.1 Consumables
11.6.2 Instruments
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Point-of-Care Coagulation Testing Market Size Forecast by Applications
11.10.1 Hospitals And Private Clinics
11.10.2 Home Care
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Point-of-Care Coagulation Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Point-of-Care Coagulation Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Point-of-Care Coagulation Testing Market Size Forecast by Type
12.6.1 Consumables
12.6.2 Instruments
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Point-of-Care Coagulation Testing Market Size Forecast by Applications
12.10.1 Hospitals And Private Clinics
12.10.2 Home Care
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Point-of-Care Coagulation Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Point-of-Care Coagulation Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Point-of-Care Coagulation Testing Market Size Forecast by Type
13.6.1 Consumables
13.6.2 Instruments
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Point-of-Care Coagulation Testing Market Size Forecast by Applications
13.10.1 Hospitals And Private Clinics
13.10.2 Home Care
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Point-of-Care Coagulation Testing Market: Competitive Dashboard
14.2 Global Point-of-Care Coagulation Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 F.Hoffmann-La Roche
14.3.2 Abbott
14.3.3 Siemens Healthcare
14.3.4 Accriva Diagnostics
14.3.5 CoaquSense
14.3.6 Diagon
14.3.7 Helena Point of Care
14.3.8 HemoSonics
14.3.9 iLine Microsystems
14.3.10 Medtronic
14.3.11 Micropoint Bioscience
14.3.12 Sysmex
